Oncology Heard on the pipeline: Technology in oncology It’s not every day that experts from across the oncology field gather in one place to discuss the past, present, and future of cancer treatment.
News BioMarin snaps up Alesta's lead asset for $275M BioMarin will acquire Alesta's experimental therapy for rare bone disease hypophosphatasia for up to $490 million.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.